Repeated tissue biopsies are necessary to identify histological changes in complex cancers and to elucidate resistance mechanisms if the combination treatment of a PD-1 inhibitor, anti-VEGF therapy, and chemotherapy fails. This evidence concerns the gene PDCD1 and cancer.